GlassScriptPhysician profile
Mathew A Cline
NPI 1699193250
$3,255.62
in general payments reported to CMS, 2019-2025
30 companies · $802 in 2025
The $802 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.13 · 2020: $98.98 · 2021: $782 · 2022: $705 · 2023: $517 · 2024: $286 · 2025: $802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,210 · Long Term Medical Supply Or Device Loan: $395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,210.42 |
| Long Term Medical Supply Or Device Loan | $394.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $550.24 | 2019-2023 | Augment Injectable, Allopure, Infinity |
| Organogenesis INC. | $544.29 | 2021-2024 | Puraply |
| Integra Lifesciences Corporation | $414.48 | 2025 | Cytal, Integra, Primatrix |
| Orthofix Medical, INC. | $333.46 | 2020-2025 | Physio-Stim |
| Horizon Therapeutics Plc | $276.43 | 2021-2023 | Krystexxa |
| Smith+Nephew, INC. | $182.51 | 2020-2024 | Collagenase Santyl, Regranex, Grafix Pl |
| Forthright Medical - Az, LLC | $95.62 | 2024 | |
| Mimedx Group, INC. | $90.47 | 2024-2025 | |
| Impactortho, INC. | $89.73 | 2023-2025 | |
| Amgen INC. | $84.40 | 2024-2025 | Krystexxa |
| Bioventus LLC | $72.60 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Surgenex LLC | $62.87 | 2025 | Surmatrix, Renograft, Pellograft |
| Grt US Holding, INC. | $46.91 | 2021 | |
| Paratek Pharmaceuticals, INC. | $41.44 | 2022-2023 | Nuzyra |
| Advanced Oxygen Therapy INC. | $37.62 | 2021-2023 | Topical Oxygen Chamber For Extremities |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $32.32 | 2021 | |
| Nevro Corp. | $31.86 | 2022-2023 | Senza |
| Nalu Medical, INC. | $30.42 | 2025 | Nalu Neurostimulation System |
| Abbvie INC. | $29.63 | 2023 | Dalvance |
| Biotissue Holdings INC. | $25.99 | 2021 | |
| Melinta Therapeutics, LLC | $25.38 | 2022 | |
| Tactile Systems Technology INC | $24.23 | 2025 | Nimbl, Flexitouch Plus |
| Globus Medical, INC. | $23.30 | 2025 | Anthem, Captivate |
| Abbott Laboratories | $19.33 | 2023 | Proclaim |
| Solventum Corporation | $18.81 | 2024 | Activ.A.C. |
| Ibsa Pharma INC. | $18.29 | 2023 | Tirosint, Licart |
| Trilliant Surgical LLC. | $15.73 | 2019 | |
| Next Science LLC | $14.39 | 2022 | |
| Osteomed LLC | $13.85 | 2021 | |
| Medela LLC | $9.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mathew Cline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.